The Ensign Group (NASDAQ:ENSG) Stock Rating Lowered by Wall Street Zen

The Ensign Group (NASDAQ:ENSG) was downgraded by investment analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a note issued to investors on Saturday, Wall Street Zen reports.

Several other analysts have also recently weighed in on the company. Truist Financial boosted their price target on The Ensign Group from $202.00 to $207.00 and gave the stock a “hold” rating in a report on Thursday, July 30th. Royal Bank Of Canada reiterated an “outperform” rating and issued a $228.00 price objective on shares of The Ensign Group in a report on Tuesday, July 28th. Finally, Weiss Ratings upgraded shares of The Ensign Group from a “buy (b-)” rating to a “buy (b)” rating in a report on Thursday, October 8th. Four analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $216.25.

The Ensign Group Price Performance

Shares of NASDAQ:ENSG opened at $176.63 on Friday. The Ensign Group has a 52-week low of $141.58 and a 52-week high of $218.00. The company has a market capitalization of $10.29 billion, a PE ratio of 27.68, a price-to-earnings-growth ratio of 1.67 and a beta of 0.66. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.21 and a current ratio of 1.21. The company has a fifty day moving average of $175.42 and a 200-day moving average of $175.42.

The Ensign Group (NASDAQ:ENSG) last released its quarterly earnings data on Monday, July 27th. The company reported $1.92 earnings per share for the quarter, beating the consensus estimate of $1.80 by $0.12. The Ensign Group had a return on equity of 16.75% and a net margin of 6.90%. The company had revenue of $1.44 billion for the quarter, compared to the consensus estimate of $1.44 billion. During the same quarter last year, the business posted $1.59 EPS. The Ensign Group’s revenue for the quarter was up 16.7% on a year-over-year basis. The Ensign Group has set its FY 2026 guidance at 7.750-7.850 EPS. On average, equities analysts predict that The Ensign Group will post 7.04 EPS for the current fiscal year.

Institutional Trading of The Ensign Group

Institutional investors and hedge funds have recently bought and sold shares of the stock. Dockside LLC bought a new stake in The Ensign Group in the second quarter valued at approximately $2,180,000. Wasatch Advisors LP increased its position in The Ensign Group by 10.7% during the 2nd quarter. Wasatch Advisors LP now owns 2,278,324 shares of the company’s stock valued at $365,215,000 after purchasing an additional 220,329 shares during the period. Oppenheimer Asset Management Inc. bought a new position in The Ensign Group during the 2nd quarter worth approximately $8,619,000. Nykredit A S bought a new position in The Ensign Group during the 2nd quarter worth approximately $462,000. Finally, NewEdge Wealth LLC bought a new position in The Ensign Group during the 2nd quarter worth approximately $8,518,000. 96.12% of the stock is currently owned by institutional investors and hedge funds.

The Ensign Group News Roundup

Here are the key news stories impacting The Ensign Group this week:

• Neutral Sentiment: Investors who purchased Ensign securities between February 10, 2022, and June 18, 2026, may seek appointment as lead plaintiff in the pending federal class action. The deadline to file that motion is December 7, 2026. Kaplan Fox announcement
• Negative Sentiment: Multiple investor-rights firms, including Rosen Law Firm, Kaplan Fox, Robbins Geller and others, are soliciting investors in connection with the same lawsuit. The repeated announcements increase the visibility of the allegations and add to investor uncertainty. Rosen Law Firm announcement
• Negative Sentiment: The complaint alleges that Ensign and certain executives made false or misleading statements or failed to disclose material information during the class period. These are allegations, not established findings, but potential legal damages, defense costs, management distraction and reputational harm can weigh on valuation. Robbins Geller announcement

About The Ensign Group

The Ensign Group, Inc (NASDAQ: ENSG) is a healthcare services company that operates through a network of skilled nursing, rehabilitation and senior living facilities. Its centers provide post-acute care, including nursing services, physical, occupational and speech therapy, short-term rehabilitation, and long-term residential care for older adults and patients recovering from illness, injury or surgery.

The company also provides home health and hospice services, as well as a range of ancillary services supporting post-acute care.